OraSure Technologies, Inc.
OraSure Technologies provides diagnostic tests and products for point-of-care and home use. Products include COVID-19 rapid tests, HIV/HCV tests, drug testing systems, and genomic collection devices. The company also offers microbiome laboratory and analytical services. Additional products include immunoassays, in vitro diagnostic tests, and saliva alcohol test kits. OraSure markets its products to various industries, including clinical laboratories, hospitals, and government agencies. The company was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Overview
Sector
Medical Instruments & Supplies
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 0.0%) has been below its cost of capital of 12.7% in 5 of the last 6 years.
- Our discounted cash flow model finds no value to support the current price: free cash flow is negative.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 4 of the last 6 years.
- High leverage: net debt is 3.4x EBITDA, against a median of 1.8x for its Medical Instruments & Supplies peers.
- Unstable profitability: operating margin ranged from -59% to 11% over the last 6 years, with operating losses in 5 of them.
Key Financial Data